Scientific Fat Loss
The Pharma Data
MAY 16, 2021
Perhaps more than ever before in human history, we are facing a daily onslaught of toxins that many people are largely unaware of.
Cosmetics Hormones Medicine Vaccine 
52 
Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVID-19
Pfizer
AUGUST 15, 2022
I am grateful to have received four doses of the Pfizer-BioNTech vaccine and I am feeling well while experiencing very mild symptoms. I am incredibly grateful for the tireless efforts of my Pfizer colleagues who worked to make vaccines and treatments available for me and people around the world. COVID-19, Vaccines. 07.19.2022.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pfizer to Provide U.S. Government with an Additional 3.7 Million Treatment Courses of PAXLOVID™ to Help Combat COVID-19
Pfizer
DECEMBER 13, 2022
PAXLOVID is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of PAXLOVID under 564(b)(1) of the Food Drug and Cosmetic Act, unless the authorization is terminated or revoked sooner. COVID-19 Medicines Partnerships. Research Vaccines. Partnerships.
Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. billion in 2022.
Pfizer Signs Agreement to Provide the European Union with PAXLOVID™
Pfizer
NOVEMBER 23, 2022
Expanding Access to Patent-Protected Medicines in Lower-Income Countries : Launched An Accord for a Healthier World , a first-of-its-kind initiative to enable sustained, equitable access to high-quality medicines and vaccines for 1.2 Contraception: Use of ritonavir may reduce the efficacy of combined hormonal contraceptives.
U.S. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™
Pfizer
DECEMBER 20, 2022
The extension of the NDA review period will not impact the Emergency Use Authorization (EUA) or the current availability of the medicine for eligible patients. Contraception: Use of ritonavir may reduce the efficacy of combined hormonal contraceptives. COVID-19 Medicines Partnerships. Research Vaccines. In the U.S.,
Let's personalize your content